Stock Market LIVE: Nifty, Sensex Rangebound; Asian Paints, IndiGo, RIL Top Gainers

Good afternoon, welcome to our blog for live market coverage. The Nifty 50 and Sensex were trading in a narrow range after erasing all gains from the open. Indoco Remedies dropped sharply after reporting a loss for the July–September period. Redington share price jumped over 13%. Hindalco Industries share price fell over 7%.

Nifty Consolidates Ahead of Major Earnings

The Indian stock market has been witnessing a range-bound movement, with the Nifty 50 and Sensex indices trading in a narrow range. This consolidation is expected to continue ahead of the major earnings season, which is set to begin soon. Investors are advised to keep a close eye on the Q2 earnings reports of top companies, as they will provide valuable insights into the health of the Indian economy.

UPL Earnings Key Highlights

UPL Ltd has reported its Q2 earnings, with a net profit of Rs 553 crore, compared to a loss of Rs 443 crore in the same period last year. The company’s revenue rose 8.4% to Rs 12,019 crore, while Ebitda increased 48% to Rs 2,001 crore. The margin stood at 16.6%, compared to 12.2% in the previous year. The company also reported a one-time gain of Rs 142 crore in the second quarter.

For more information on UPL Q2 earnings, please visit our website.

State Bank of India to Take Asset Management Arm Public

State Bank of India (SBI) is set to take its asset management arm public, with the executive committee of the lender’s board approving a partial divestment of its stake in SBI Funds Management Limited (SBIFML) through an Initial Public Offering (IPO). This move is expected to provide a boost to the Indian stock market, as it will provide investors with an opportunity to invest in a leading asset management company.

For more information on SBI Asset Management IPO, please visit our website.

Abbott India Q2 Earnings Key Highlights

Abbott India has reported its Q2 earnings, with a net profit of Rs 415 crore, up 15.8% from Rs 359 crore in the same period last year. The company’s revenue rose 7.6% to Rs 1,757 crore, while Ebitda increased 14.4% to Rs 502 crore. The margin stood at 28.6%, compared to 26.9% in the previous year.

For more information on Abbott India Q2 earnings, please visit our website.

Zydus Lifesciences Q2 Highlights

Zydus Lifesciences has reported its Q2 earnings, with revenue up 16.9% to Rs 6,123.00 crore, compared to Rs 5,237.00 crore in the same period last year. The company’s net profit increased 38% to Rs 1,258.60 crore, compared to Rs 911.20 crore in the previous year.

For more information on Zydus Lifesciences Q2 earnings, please visit our website.

Epack Prefab Technologies Receives Orders Worth Rs 175 Crore

Epack Prefab Technologies has received orders worth Rs 175 crore from Inox Neo Energies and Reliance Industries Ltd, the company said in an exchange filing. This development is expected to provide a boost to the company’s stock price, as it indicates a strong demand for its products.

For more information on Epack Prefab Technologies orders, please visit our website.

Indian Stock Market: What to Expect in the Coming Weeks

The Indian stock market is expected to remain volatile in the coming weeks, with the Q2 earnings season set to begin soon. Investors are advised to keep a close eye on the earnings reports of top companies, as they will provide valuable insights into the health of the Indian economy. Additionally, the ongoing geopolitical tensions and the COVID-19 pandemic are expected to continue to impact the market, making it essential for investors to stay informed and up-to-date with the latest developments.

For more information on Indian stock market news, please visit our website.

Conclusion

In conclusion, the Indian stock market has been witnessing a range-bound movement, with the Nifty 50 and Sensex indices trading in a narrow range. The Q2 earnings season is set to begin soon, and investors are advised to keep a close eye on the earnings reports of top companies. Additionally, the ongoing geopolitical tensions and the COVID-19 pandemic are expected to continue to impact the market, making it essential for investors to stay informed and up-to-date with the latest developments.